{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T09:00:52Z","timestamp":1792314052477,"version":"4.4.0"},"reference-count":55,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T00:00:00Z","timestamp":1617062400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81703682"],"award-info":[{"award-number":["81703682"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81773961"],"award-info":[{"award-number":["81773961"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81920108033"],"award-info":[{"award-number":["81920108033"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["R01DK124627"],"award-info":[{"award-number":["R01DK124627"]}],"id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004921","name":"Shanghai Jiao Tong University","doi-asserted-by":"publisher","award":["YG2019QNA03"],"award-info":[{"award-number":["YG2019QNA03"]}],"id":[{"id":"10.13039\/501100004921","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Acta Pharmaceutica Sinica B"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.apsb.2021.03.038","type":"journal-article","created":{"date-parts":[[2021,3,30]],"date-time":"2021-03-30T19:29:59Z","timestamp":1617132599000},"page":"1541-1554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["Notoginsenoside Ft1 acts as a TGR5 agonist but FXR antagonist to alleviate high fat diet-induced obesity and insulin resistance in mice"],"prefix":"10.1016","volume":"11","author":[{"given":"Lili","family":"Ding","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eryun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yangmeng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siming","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengcai","family":"Ju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linshan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunjiang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengtao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.apsb.2021.03.038_bib1","first-page":"165","article-title":"The clinical biochemistry of obesity","volume":"25","author":"Sikaris","year":"2004","journal-title":"Clin Biochem Rev"},{"key":"10.1016\/j.apsb.2021.03.038_bib2","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1056\/NEJMoa021423","article-title":"Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults","volume":"348","author":"Calle","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.apsb.2021.03.038_bib3","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1002\/2327-6924.12510","article-title":"Obesity: risk factors, complications, and strategies for sustainable long-term weight management","volume":"29","author":"Fruh","year":"2017","journal-title":"J Am Assoc Nurse Pract"},{"key":"10.1016\/j.apsb.2021.03.038_bib4","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.7150\/ijms.27953","article-title":"Phenotypic alteration of hepatocytes in non-alcoholic fatty liver disease","volume":"15","author":"Lakhani","year":"2018","journal-title":"Int J Med Sci"},{"key":"10.1016\/j.apsb.2021.03.038_bib5","doi-asserted-by":"crossref","first-page":"547","DOI":"10.2147\/CIA.S248158","article-title":"Profile of obesity and comorbidities in elderly patients with heart failure","volume":"15","author":"D\u0103d\u00e2rlat-Pop","year":"2020","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.apsb.2021.03.038_bib6","series-title":"Obesity and overweight","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.apsb.2021.03.038_bib7","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.2337\/dc15-1081","article-title":"Advances in the science, treatment, and prevention of the disease of obesity: reflections from a Diabetes Care Editors' Expert Forum","volume":"38","author":"Cefalu","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.apsb.2021.03.038_bib8","doi-asserted-by":"crossref","first-page":"853501","DOI":"10.1155\/2011\/853501","article-title":"TGR5: a novel target for weight maintenance and glucose metabolism","volume":"2011","author":"Chen","year":"2011","journal-title":"Exp Diabetes Res"},{"key":"10.1016\/j.apsb.2021.03.038_bib9","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.cmet.2009.08.001","article-title":"TGR5-mediated bile acid sensing controls glucose homeostasis","volume":"10","author":"Thomas","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/j.apsb.2021.03.038_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/s41467-017-02068-0","article-title":"TGR5 signalling promotes mitochondrial fission and beige remodelling of white adipose tissue","volume":"9","author":"Velazquez-Villegas","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2021.03.038_bib11","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0006-291X(02)02550-0","article-title":"Identification of membrane-type receptor for bile acids (M-BAR)","volume":"298","author":"Maruyama","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2021.03.038_bib12","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1124\/pr.113.008201","article-title":"Bile acid signaling in metabolic disease and drug therapy","volume":"66","author":"Li","year":"2014","journal-title":"Pharmacol Rev"},{"key":"10.1016\/j.apsb.2021.03.038_bib13","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.dld.2013.10.021","article-title":"The bile acid TGR5 membrane receptor: from basic research to clinical application","volume":"46","author":"Duboc","year":"2014","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.apsb.2021.03.038_bib14","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nature04330","article-title":"Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation","volume":"439","author":"Watanabe","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.apsb.2021.03.038_bib15","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1042\/CS20150154","article-title":"The regulation of function, growth and survival of GLP-1-producing L-cells","volume":"130","author":"Kuhre","year":"2016","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.apsb.2021.03.038_bib16","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3389\/fphys.2014.00420","article-title":"Release of GLP-1 and PYY in response to the activation of G protein-coupled bile acid receptor TGR5 is mediated by Epac\/PLC-\u03b5 pathway and modulated by endogenous H2S","volume":"5","author":"Bala","year":"2014","journal-title":"Front Physiol"},{"key":"10.1016\/j.apsb.2021.03.038_bib17","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/hep.24525","article-title":"The G-protein-coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor \u03ba light-chain enhancer of activated B cells (NF-\u03baB) in mice","volume":"54","author":"Wang","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.03.038_bib18","doi-asserted-by":"crossref","first-page":"7958","DOI":"10.1021\/jm901390p","article-title":"Discovery of 6alpha-ethyl-23(S)-methylcholic acid (S-EMCA, INT-777) as a potent and selective agonist for the TGR5 receptor, a novel target for diabesity","volume":"52","author":"Pellicciari","year":"2009","journal-title":"J Med Chem"},{"key":"10.1016\/j.apsb.2021.03.038_bib19","doi-asserted-by":"crossref","first-page":"646","DOI":"10.3389\/fphys.2016.00646","article-title":"TGR5, not only a metabolic regulator","volume":"7","author":"Guo","year":"2016","journal-title":"Front Physiol"},{"key":"10.1016\/j.apsb.2021.03.038_bib20","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1177\/1756283X16630712","article-title":"Novel bile acid therapeutics for the treatment of chronic liver diseases","volume":"9","author":"Hegade","year":"2016","journal-title":"Therap Adv Gastroenterol"},{"key":"10.1016\/j.apsb.2021.03.038_bib21","first-page":"1449","article-title":"Targeting FXR in cholestasis: hype or hope","volume":"18","author":"Fiorucci","year":"2014","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.apsb.2021.03.038_bib22","doi-asserted-by":"crossref","first-page":"3295","DOI":"10.1113\/jphysiol.2010.192146","article-title":"Hydrophobic bile salts inhibit gallbladder smooth muscle function via stimulation of GPBAR1 receptors and activation of KATP channels","volume":"588","author":"Lavoie","year":"2010","journal-title":"J Physiol"},{"key":"10.1016\/j.apsb.2021.03.038_bib23","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3109\/10799893.2013.802805","article-title":"The bile acid membrane receptor TGR5: a novel pharmacological target in metabolic, inflammatory and neoplastic disorders","volume":"33","author":"Stepanov","year":"2013","journal-title":"J Recept Signal Transduct Res"},{"key":"10.1016\/j.apsb.2021.03.038_bib24","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1124\/jpet.113.210005","article-title":"G protein-coupled bile acid receptor 1 stimulation mediates arterial vasodilation through a K(Ca)1.1 (BK(Ca))-dependent mechanism","volume":"348","author":"Fryer","year":"2014","journal-title":"J Pharmacol Exp Therapeut"},{"key":"10.1016\/j.apsb.2021.03.038_bib25","first-page":"45","article-title":"Pharmacological studies on notoginseng saponins isolated from the fibrous root of Panax notoginseng","volume":"12","author":"Chen","year":"1987","journal-title":"Bull Chin Mater Med"},{"key":"10.1016\/j.apsb.2021.03.038_bib26","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1002\/hlca.200690144","article-title":"New dammarane monodesmosides from the acidic deglycosylation of notoginseng-leaf saponins","volume":"89","author":"Chen","year":"2006","journal-title":"Helv Chim Acta"},{"key":"10.1016\/j.apsb.2021.03.038_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093567","article-title":"GPBAR1\/TGR5 mediates bile acid-induced cytokine expression in murine Kupffer cells","volume":"9","author":"Lou","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.apsb.2021.03.038_bib28","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1210\/endo.142.10.8415","article-title":"A human cellular model for studying the regulation of glucagon-like peptide-1 secretion","volume":"142","author":"Reimer","year":"2001","journal-title":"Endocrinology"},{"key":"10.1016\/j.apsb.2021.03.038_bib29","doi-asserted-by":"crossref","first-page":"10166","DOI":"10.1038\/ncomms10166","article-title":"Intestine-selective farnesoid X receptor inhibition improves obesity-related metabolic dysfunction","volume":"6","author":"Jiang","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.apsb.2021.03.038_bib30","first-page":"1863","article-title":"Beneficial effect of resveratrol on \u03b1-naphthyl isothiocyanate-induced cholestasis via regulation of the FXR pathway","volume":"17","author":"Ding","year":"2018","journal-title":"Mol Med Rep"},{"key":"10.1016\/j.apsb.2021.03.038_bib31","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1042\/BJ20060537","article-title":"Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation","volume":"398","author":"Vassileva","year":"2006","journal-title":"Biochem J"},{"key":"10.1016\/j.apsb.2021.03.038_bib32","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1021\/tx800225q","article-title":"Bile acids metabonomics study on the CCl4- and \u03b1-naphthylisothiocyanate-induced animal models: quantitative analysis of 22 bile acids by ultraperformance lipid chromatography-mass spectrometry","volume":"21","author":"Yang","year":"2008","journal-title":"Chem Res Toxicol"},{"key":"10.1016\/j.apsb.2021.03.038_bib33","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1002\/hep.28707","article-title":"G protein-coupled bile acid receptor plays a key role in bile acid metabolism and fasting-induced hepatic steatosis","volume":"65","author":"Donepudi","year":"2017","journal-title":"Hepatology"},{"key":"10.1016\/j.apsb.2021.03.038_bib34","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2010.12.004","article-title":"The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation","volume":"54","author":"Pols","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/j.apsb.2021.03.038_bib35","doi-asserted-by":"crossref","first-page":"d176","DOI":"10.2741\/A273","article-title":"Regulation of bile acid synthesis","volume":"3","author":"Chiang","year":"1998","journal-title":"Front Biosci"},{"key":"10.1016\/j.apsb.2021.03.038_bib36","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3748\/wjg.15.804","article-title":"Bile acids: chemistry, physiology, and pathophysiology","volume":"15","author":"Monte","year":"2009","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.apsb.2021.03.038_bib37","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S1097-2765(00)80348-2","article-title":"Endogenous bile acids are ligands for the nuclear receptor FXR\/BAR","volume":"3","author":"Wang","year":"1999","journal-title":"Mol Cell"},{"key":"10.1016\/j.apsb.2021.03.038_bib38","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1126\/science.284.5418.1365","article-title":"Bile acids: natural ligands for an orphan nuclear receptor","volume":"284","author":"Parks","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.apsb.2021.03.038_bib39","doi-asserted-by":"crossref","first-page":"S237","DOI":"10.2337\/dc09-S355","article-title":"Bile acids and metabolic regulation: mechanisms and clinical responses to bile acid sequestration","volume":"32 Suppl 2","author":"Staels","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.apsb.2021.03.038_bib40","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1677\/joe.1.06546","article-title":"Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1\/M-Bar) in mice","volume":"191","author":"Maruyama","year":"2006","journal-title":"J Endocrinol"},{"key":"10.1016\/j.apsb.2021.03.038_bib41","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0006-291X(02)02550-0","article-title":"Identification of membrane-type receptor for bile acids (M-BAR)","volume":"298","author":"Maruyama","year":"2002","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.apsb.2021.03.038_bib42","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.apsb.2015.01.004","article-title":"Bile acid nuclear receptor FXR and digestive system diseases","volume":"5","author":"Ding","year":"2015","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2021.03.038_bib43","doi-asserted-by":"crossref","first-page":"G412","DOI":"10.1152\/ajpgi.00300.2018","article-title":"Intestinal TGR5 agonism improves hepatic steatosis and insulin sensitivity in Western diet-fed mice","volume":"316","author":"Finn","year":"2019","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/j.apsb.2021.03.038_bib44","doi-asserted-by":"crossref","first-page":"2718","DOI":"10.2174\/1568026619666191112121330","article-title":"Herbal medicine of the 21st century:\u00a0a focus on the chemistry, pharmacokinetics and toxicity of five widely advocated phytotherapies","volume":"19","author":"Suroowan","year":"2019","journal-title":"Curr Top Med Chem"},{"key":"10.1016\/j.apsb.2021.03.038_bib45","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.apsb.2019.11.017","article-title":"Herbal drug discovery for the treatment of nonalcoholic fatty liver disease","volume":"10","author":"Yan","year":"2020","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2021.03.038_bib46","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.3390\/molecules24132365","article-title":"Recent advances in biotransformation of saponins","volume":"24","author":"He","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.apsb.2021.03.038_bib47","doi-asserted-by":"crossref","first-page":"246","DOI":"10.4103\/2319-4170.130922","article-title":"Mammalian gut immunity","volume":"37","author":"Chassaing","year":"2014","journal-title":"Biomed J"},{"key":"10.1016\/j.apsb.2021.03.038_bib48","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.15252\/embj.201490686","article-title":"Generating human intestinal tissues from pluripotent stem cells to study development and disease","volume":"34","author":"Sinagoga","year":"2015","journal-title":"EMBO J"},{"key":"10.1016\/j.apsb.2021.03.038_bib49","doi-asserted-by":"crossref","first-page":"47","DOI":"10.21037\/tgh.2018.07.06","article-title":"Branched-chain amino acids in liver diseases","volume":"3","author":"Tajiri","year":"2018","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/j.apsb.2021.03.038_bib50","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1038\/s41591-019-0509-0","article-title":"Gut microbiota-bile acid-interleukin-22 axis orchestrates polycystic ovary syndrome","volume":"25","author":"Qi","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2021.03.038_bib51","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-19-0399","article-title":"Mechanisms controlling hormone secretion in human gut and its relevance to metabolism","volume":"244","author":"Martin","year":"2019","journal-title":"J Endocrinol"},{"key":"10.1016\/j.apsb.2021.03.038_bib52","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1038\/s41591-018-0222-4","article-title":"Gut microbiota and intestinal FXR mediate the clinical benefits of metformin","volume":"24","author":"Sun","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.apsb.2021.03.038_bib53","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1053\/j.gastro.2016.08.057","article-title":"An intestinal microbiota-farnesoid X receptor axis modulates metabolic disease","volume":"151","author":"Gonzalez","year":"2016","journal-title":"Gastroenterology"},{"key":"10.1016\/j.apsb.2021.03.038_bib54","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.apsb.2019.02.004","article-title":"Ablation of gut microbiota alleviates obesity-induced hepatic\u00a0steatosis and glucose intolerance by modulating bile\u00a0acid metabolism in hamsters","volume":"9","author":"Sun","year":"2019","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.apsb.2021.03.038_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2020.11.017","article-title":"Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism","volume":"33","author":"Zheng","year":"2021","journal-title":"Cell Metab"}],"container-title":["Acta Pharmaceutica Sinica B"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521001106?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211383521001106?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:48:59Z","timestamp":1761929339000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211383521001106"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":55,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2211383521001106"],"URL":"https:\/\/doi.org\/10.1016\/j.apsb.2021.03.038","relation":{},"ISSN":["2211-3835"],"issn-type":[{"value":"2211-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Notoginsenoside Ft1 acts as a TGR5 agonist but FXR antagonist to alleviate high fat diet-induced obesity and insulin resistance in mice","name":"articletitle","label":"Article Title"},{"value":"Acta Pharmaceutica Sinica B","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.apsb.2021.03.038","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.","name":"copyright","label":"Copyright"}]}}